Cargando…
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
The classical factors for predicting prognosis currently cannot meet the developing requirements of individualized and accurate prognostic evaluation in lung adenocarcinoma (LUAD). With the rapid development of high-throughput DNA sequencing technologies, genomic changes have been discovered. These...
Autores principales: | Li, Baihui, Huang, Ziqi, Yu, Wenwen, Liu, Shaochuan, Zhang, Jian, Wang, Qingqing, Wu, Lei, Kou, Fan, Yang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208901/ https://www.ncbi.nlm.nih.gov/pubmed/34139453 http://dx.doi.org/10.1016/j.neo.2021.05.006 |
Ejemplares similares
-
Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021) -
Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy
por: Kou, Fan, et al.
Publicado: (2022) -
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023) -
Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma
por: Feng, Caihou, et al.
Publicado: (2022) -
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
por: Kou, Fan, et al.
Publicado: (2022)